ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness. Forteo® (teriparatide injection) is indicated to ...
Forteo (teriparatide) is a brand-name drug that doctors prescribe for some people with osteoporosis. It contains proteins that strengthen bones and stimulate new bone growth. A typical prescription is ...
BEECH ISLAND, S.C.--(BUSINESS WIRE)--Ambio, Inc., an innovative biotech company developing novel peptide drugs, biosimilar, bioequivalent, and other complex generic drugs, announced today that a ...
RANCHO CUCAMONGA, CA / ACCESS Newswire / May 27, 2026 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that ... · ACCESS Newswire · Amphastar Pharmaceuticals, Inc. Amphastar ...
Teva Pharmaceuticals has received the Food and Drug Administration’s approval for generic Forteo. The product is expected to be available in the coming weeks. “We are thrilled to receive the ...
Teva Pharmaceuticals Inc., a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA), announced today the approval of a generic version of Forteo®1, in the United States. Market ...
Forteo® (teriparatide injection) is indicated to treat osteoporosis among certain women and men. This approval showcases Teva’s proven strengths in complex generic formulations development and device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results